Various factors such as hypoxia, an acidic milieu, elevated adenosine levels, NK cell surface receptors, TGF-β, interleukins, and exosomes all contribute to modulating the anti-tumor effects of CAR-NK cells. The gene discussed is TGFB1; the disease is neoplasm.